Related by context. All words. (Click for frequent words.) 69 angiogenesis inhibitors 68 VEGF vascular endothelial 67 vascular disrupting agents 66 angiogenesis inhibitor 66 anti angiogenic 65 antiangiogenic 65 molecularly targeted 65 antiangiogenesis 65 mTOR inhibitors 64 potent anticancer 64 vascular endothelial growth 63 angiogenesis 63 histone deacetylase inhibitors 63 VEGF inhibitors 63 CTLA 4 63 VEGF receptor 63 pro angiogenic 63 proteasome inhibitors 63 selective inhibition 63 Panzem 62 antitumor 62 VEGF 62 anti angiogenic agent 62 hedgehog pathway 62 pertuzumab 62 multitargeted 62 HuLuc# 62 vascular disrupting agent 62 tyrosine kinase inhibitor 62 inhibiting angiogenesis 62 inhibit angiogenesis 62 CA4P 62 GSK3 61 BRAF inhibitors 61 Nanobody 61 Tarvacin 61 deacetylase inhibitors 61 cediranib 61 novel anticancer 61 Vascular Endothelial Growth 61 anticancer agents 61 cancer immunotherapy 61 proteasome inhibitor 61 antisense 61 taxol 61 anticancer therapy 61 histone deacetylase HDAC inhibitors 61 BRAF inhibitor 61 TNFα 61 PDE# 61 Pertuzumab 61 IAP inhibitor 61 incretin 61 ixabepilone 61 neurotrophic 60 anticancer compounds 60 PLX# 60 anti VEGF 60 Zolinza 60 obatoclax 60 tyrosine kinase inhibitors 60 BZL# 60 angiogenesis inhibition 60 novel peptide 60 Anti angiogenic 60 inhibiting tumor 60 Hedgehog signaling pathway 60 PI3K inhibitor 60 AEG# 60 OXi# 60 kinase inhibitors 60 renin inhibitors 60 EGF receptor 60 Squalamine 60 anticancer agent 60 EGFR pathway 60 tubulin binding 60 signal transduction inhibitor 60 potent antiproliferative 60 cytostatic 60 anti angiogenic drugs 60 mertansine 60 cancer immunotherapies 60 investigational humanized monoclonal antibody 60 sclerostin 59 chemotherapeutic drug 59 disease modifying 59 DFMO 59 Curaxin 59 RNAi therapeutic targeting 59 chimeric monoclonal antibody 59 tranilast 59 epothilones 59 cyclooxygenase 59 RANK ligand 59 multi kinase inhibitor 59 TLR9 agonists 59 anticancer drugs 59 CBLC# 59 Ontak 59 LPA1 receptor 59 Hedgehog pathway 59 GAP #B# 59 small molecule tyrosine 59 BAY #-# 59 DCVax R 59 histone deacetylase HDAC 59 immunomodulatory 59 PI3K inhibitors 59 antibody fragment 59 antiinflammatory 59 chemopreventive agent 59 thymidylate synthase 59 PI3K/mTOR 59 antisense oligonucleotide 59 JAK3 inhibitor 59 CCR2 59 mTOR 59 investigational therapies 59 endostatin 59 Factor Xa inhibitor 59 isoform selective 59 MEK inhibitors 59 LY# [003] 59 inhibit EGFR 59 Ii protein 59 Affinitak 59 antisense oligonucleotides 59 neuroprotectant 59 inhibit VEGF 59 IGF 1R 59 HSP# inhibitor 59 oral Factor Xa 59 insulin sensitizing 59 targeting CD# 59 antisense drug 59 CXCR4 receptor 59 erlotinib Tarceva 58 Bevasiranib 58 inhibit tumor 58 Ceflatonin 58 antiproliferative effects 58 optimized siRNA 58 apoptosis inducing 58 HDAC inhibitors 58 thalidomide Thalomid 58 Axitinib 58 oncolytic virus 58 OMP #M# 58 C5aR 58 anti mitotic 58 Crizotinib 58 protein tyrosine phosphatase 1B 58 Symadex 58 protein kinase inhibitor 58 glucagon receptor 58 JAK3 58 antithrombotic 58 HDAC 58 chemically modified siRNA 58 PARP inhibitors 58 Xanafide 58 selective estrogen receptor 58 RANK Ligand 58 anticancer therapies 58 BiTE 58 BN# [002] 58 Tyrima 58 receptor tyrosine kinase inhibitor 58 CYT# potent vascular disrupting 58 PI3 kinase 58 MLN# 58 Onconase 58 Stapled Peptide 58 Mipomersen 58 anti CD3 58 SIRT1 activation 58 HDAC inhibition 58 Aflibercept 58 NFkB 58 oncolytic viruses 58 antisense drugs 58 Smac mimetic 58 flavopiridol 58 enzyme inhibitors 58 osteoclast activity 58 Factor VIIa 58 Anti VEGF 58 BRAF kinase 58 SGLT inhibitors 58 p# inhibitors 58 FGFR 58 bevacizumab Avastin 58 VEGF Trap 58 bioactive lipids 58 stapled peptides 58 metaglidasen 58 PEG SN# 58 Vandetanib 58 muscarinic 58 neovascularization 58 phosphoinositide 3 58 CYC# 58 VEGFR 58 kinase inhibitor 58 peptibody 58 Litx 58 trastuzumab DM1 58 mimetics 58 HyACT 57 EGFr 57 immune modulator 57 Olaparib 57 PXD# 57 HDACi 57 uric acid lowering 57 HCV protease inhibitors 57 targeted radiotherapeutic 57 Fleximer 57 enzastaurin 57 Aviptadil 57 E2F Decoy 57 mGluR2 NAM 57 liposomal formulation 57 Angiocept 57 MitoQ 57 protein kinase inhibitors 57 Protein Kinase C 57 Dasatinib 57 selectively inhibit 57 EGFR inhibitors 57 anticancer 57 anti angiogenic agents 57 anti angiogenic therapies 57 Talabostat 57 RNA silencing 57 tafamidis 57 Archexin 57 leukotriene pathway 57 chemoprotective 57 Elesclomol 57 targeted antifolate 57 Enzastaurin 57 echinocandins 57 COX2 57 Imprime PGG 57 alkylating agent 57 suppresses tumor 57 SERMs 57 preclinically 57 JAK inhibitors 57 IMC A# 57 Th2 cytokines 57 PEGylated 57 HepDirect 57 ANG# 57 pharmacologic agents 57 GSK3B 57 enzyme inhibitor 57 virotherapy 57 immunomodulating 57 oncolytic 57 AMPK activators 57 androgen receptor 57 CD# antibody [001] 57 kidney urologic 57 HIV protease inhibitors 57 fenretinide 57 Nexavar sorafenib 57 immunoregulatory 57 MKC# MKC# PP 57 neuroprotection 57 Bevacizumab 57 ErbB3 HER3 57 gamma secretase inhibitors 57 A3 adenosine receptor 57 IAP inhibitors 57 oxidative stress inducer 57 antitumoral 57 Taxanes 57 Abiraterone 57 vidofludimus 57 Dapagliflozin 57 immunotoxins 57 exon skipping 57 therapeutic monoclonal antibody 57 pan HDAC inhibitor 57 interleukins 57 small molecule 57 Everolimus 57 PI3K 57 paclitaxel Taxol 57 trastuzumab Herceptin 57 phosphate S1P 57 delta isoform 57 THR beta agonist 57 immunomodulator 57 triterpenoids 57 derived neurotrophic factor 57 Antisense 57 Angiogenesis 57 systemic antifungal 57 drug conjugate 57 highly selective endothelin 57 nucleoside analog 57 dexpramipexole 57 PNP inhibitor 57 gamma secretase inhibitor 57 immuno modulatory 56 Rituxan rituximab 56 immune modulating 56 anticancer therapeutics 56 huC# DM4 56 S#P# 56 biologic therapeutics 56 clinically validated vascular endothelial 56 neuro protective 56 reperfusion injury 56 Taxol ® 56 MEK ERK 56 cytoprotective 56 lumiliximab 56 DPP4 inhibitor 56 epothilone 56 OncoVex 56 PKC# 56 JAK1 56 neuronal nicotinic receptors NNRs 56 monoclonal antibody therapeutics 56 HDAC inhibitor 56 small molecule agonists 56 Aliskiren 56 thrombopoietin 56 engineered RAP peptides 56 INS# [001] 56 Factor VEGF 56 TLR9 agonist 56 ENMD # 56 PDE7 56 oral prodrug 56 Interferon beta 56 Bucindolol 56 potent anti angiogenic 56 Bryostatin 56 mTOR inhibitor 56 antiarrhythmic 56 antimetastatic 56 receptor inhibitors 56 anti secretory 56 ZFP TF 56 Factor Xa 56 Wnt signaling pathway 56 Pfizer Sutent 56 SU# [003] 56 discodermolide 56 anticlotting 56 entinostat 56 Sapacitabine 56 JAK inhibitor 56 vascular inflammation 56 lapatinib Tykerb 56 VEGF pathway 56 elesclomol 56 T DM1 56 peptidic 56 receptor agonists 56 Muraglitazar 56 Photodynamic therapy PDT 56 therapeutic monoclonal antibodies 56 CCR3 56 SGLT 2 56 P#X# 56 deforolimus 56 M2 subunit 56 rheumatoid arthritis multiple sclerosis 56 JAK2 inhibitor 56 PKCi 56 pro apoptotic 56 MEK inhibitor 56 immune modulatory 56 serotonin receptor 56 novel topoisomerase 56 Alnylam RNAi 56 novel VDA molecule 56 microtubule inhibitor 56 siRNA therapeutics 56 mTOR inhibition 56 bortezomib Velcade 56 Cabazitaxel 56 alpha folate receptor 56 chemotherapeutic agent 56 TRV# [001] 56 vascular disrupting 56 panitumumab Vectibix 56 Aplidin 56 sphingosine 1 56 LTB4 56 Sphingomab 56 anti amnesic 56 seliciclib 56 gefitinib Iressa 56 antiangiogenic agent 56 Tumour Vascular Disrupting Agent 56 humanized monoclonal antibody 56 Pralatrexate 56 Nexavar ® 56 cytotoxic 56 immunosuppressive 56 Metallophile ™ Technology 56 Nanobody ® 56 PSN# [002] 56 osteoclast 56 OHR/AVR# 56 Trastuzumab 56 diabetic kidney 56 peroxisome proliferator activated 56 AKT inhibitor 56 Locked Nucleic Acid LNA 56 novel immunomodulatory 56 Angiolix 56 SGLT Inhibitors 56 sphingolipid 56 multikinase inhibitor 56 antisense inhibition 56 Gleevec resistant 56 GRN#L 56 Arcalyst 56 inhibits protein synthesis 56 talabostat 56 oncomodulin 56 sorafenib Nexavar 56 antifibrotic 56 anti angiogenic therapy 56 Fenretinide 56 humanized monoclonal antibodies 56 serine proteases 56 anti proliferative 56 TG# [003] 56 glucocorticoid receptor 56 Vaprisol 56 TELINTRA 56 XmAb# 56 chemokine receptor 56 C5a 56 SGLT2 56 Atiprimod 56 Akt activation 56 regorafenib 56 hormone gastrin 56 antitumour 56 EndoTAG TM -1 56 radionuclide therapy 56 thromboxane A2 56 sodium glucose cotransporter 56 PI3K Akt 56 phosphatidylserine PS targeting 56 COX enzymes 56 CDDO Im 55 resolvins 55 vaccine GRNVAC1 55 Gefitinib 55 PKM2 55 Novartis Gleevec 55 TNFa 55 JAK#/JAK# 55 ganetespib 55 Tarvacin TM 55 Fleximer R 55 imatinib Gleevec ® 55 IgG1 antibody 55 Darapladib 55 tubulin inhibitor 55 DHFR 55 VEGF receptors 55 accumulate preferentially 55 Factor Receptor 55 RNAi therapeutic 55 inhibit viral replication 55 dasatinib Sprycel 55 PARP inhibitor 55 microtubule targeting 55 Tesetaxel 55 neuroprotective 55 bone morphogenetic proteins BMPs 55 NXL# 55 Leukine 55 investigational compounds 55 retinoids 55 antisense inhibitors 55 inhibit vascular endothelial 55 SOD1 55 novel peptides 55 calcineurin 55 NV1FGF 55 Arranon 55 IL# PE#QQR 55 p# MAP kinase 55 anti CD3 antibody 55 buccal delivery 55 histone deacetylase HDAC inhibitor 55 macrolide antibiotics 55 cilengitide 55 autoimmune 55 Aurora kinase 55 induces apoptosis 55 PDGF receptor 55 IGFBP2 55 teplizumab 55 chemopreventive 55 druggable targets 55 epigenetic therapies 55 riociguat 55 NMDA antagonist 55 Vidofludimus 55 inhibits tumor 55 cyclopamine 55 bryostatin 55 antitumor effect 55 HuMax CD# 55 TNF tumor necrosis 55 peripherally acting 55 MMP inhibitors 55 RANKL 55 inhibiting telomerase 55 CTLA4 Ig 55 AP# [003] 55 allergic inflammation 55 induce apoptosis 55 Bleomycin 55 alpha interferon 55 theranostic 55 metastatic colorectal 55 HGS# 55 uPA 55 ADP receptor antagonist 55 neuronal nicotinic receptor NNR 55 p# inhibitor 55 Genentech Rituxan 55 GeneICE 55 HER2 antibody 55 orally bioavailable 55 Akt inhibitor 55 hypoxia inducible factor 55 Allovectin 7 55 Phylomer ® 55 PI3K delta 55 siRNA therapeutic 55 imatinib Gleevec 55 DU #b 55 5 HT2A receptor 55 immune modulation 55 trans splicing 55 collagenase 55 relapsed leukemia 55 prescribed proton pump 55 Bortezomib 55 Pazopanib 55 ESBA# 55 DXL# 55 pigment epithelium derived 55 inhibit metastasis 55 Vidaza azacitidine 55 Herceptin trastuzumab 55 systemic RNAi 55 angiogenic 55 OncoVEX 55 carbohydrate polymers 55 anticancer treatments 55 prostaglandin synthesis 55 factor Xa 55 atrasentan 55 immunotherapeutic agent 55 beta adrenergic 55 Targretin 55 potentiator 55 PLX MS 55 Synavive 55 leukotrienes 55 alpha#beta# 55 Carfilzomib 55 IMA# 55 Treanda 55 antidiabetic 55 Abiraterone acetate 55 MT#/MEDI-# 55 IL-#/# 55 NRG1 55 adoptive immunotherapy 55 milatuzumab 55 Romidepsin 55 vasodilator 55 Atrasentan 55 NF kappaB 55 androgen receptors 55 infliximab Remicade 55 Amplimexon 55 Elvitegravir 55 DOS# 55 IMiDs R 55 PEDF 55 Panzem R NCD 55 EGFR receptor 55 chemokine 55 NF kappa B 55 beta amyloid peptide 55 Tykerb lapatinib 55 enzyme beta secretase 55 acetylcholinesterase AChE 55 potent inhibitor 55 tumor vascular disrupting 55 ligand TRAIL 55 Elotuzumab 55 inhibits Akt activation 55 gastrin 55 parthenolide 55 VEGF inhibition 55 specific lectin receptors 55 interferons 55 Aurora kinase inhibitor 55 IDH1 55 PGE2 55 thrombin receptor 55 Removab 55 Sphingomab TM 55 Hsp# inhibition 55 anti atherogenic 55 ALK inhibitor 55 heparanase 55 VA# [002] 55 SERCA2a 55 metalloenzymes 55 anti androgen 55 seliciclib CYC# 54 AMN# [001] 54 demethylating agents 54 anti fibrotic 54 Hsp# inhibitor 54 receptor inhibitor 54 cisplatin resistant 54 eIF 4E 54 cyclin dependent kinases 54 cetuximab Erbitux 54 Nanobodies ® 54 protein misfolding 54 immunotherapies 54 NNR Therapeutics 54 BNC# 54 thymidylate synthase TS 54 Cylene 54 YONDELIS 54 LY# [002] 54 NTDDS 54 tumor angiogenesis 54 Trastuzumab DM1 54 anti TNFa 54 tumor vascularization 54 therapeutic peptide 54 Pathway Inhibitor 54 TGF ß 54 NNRs 54 transdifferentiation 54 c MET 54 NS#/#A protease 54 WT1 54 Kinase inhibitors 54 RhuDex 54 mTOR mammalian target 54 proteasome inhibitor bortezomib 54 vWF 54 synthetic retinoid 54 selective kinase inhibitor 54 histone deacetylase 54 Hsp# inhibitors 54 lipid nanoparticle 54 breast cancer metastasis 54 chemotherapeutic regimen 54 Epothilones 54 Smac mimetics 54 ZD# [001] 54 2DG 54 NF kappaB activation 54 neurodegenerative diseases 54 idarubicin 54 neratinib 54 TLE3 54 Vorinostat 54 SETDB1 54 aptamer 54 TPO receptor 54 imetelstat 54 volociximab 54 Enbrel etanercept 54 Panzem NCD 54 Anticalin 54 erlotinib Tarceva ® 54 small molecule defensin 54 mTOR kinase 54 FK# 54 VAPRISOL 54 selectively inhibiting 54 ocrelizumab 54 anticancer compound 54 CCX# 54 neuroprotective properties 54 alvespimycin 54 antimitotic 54 bevacizumab Avastin ® 54 tumor vasculature 54 pediatric malignancies 54 Omacetaxine 54 selective inhibitors 54 Abbokinase 54 ENaC 54 cholesterol absorption 54 KineMed 54 Cloretazine R 54 inhibit enzymes 54 Monoclonal antibody 54 psoriasis rheumatoid arthritis 54 S1P 54 cetuximab Erbitux ® 54 fibroblast growth 54 allosteric modulator 54 TGF Beta 54 Merck KGaA Erbitux 54 HyperAcute 54 vinca alkaloid 54 molecularly targeted therapy 54 targeted biologic therapies 54 galanin 54 receptor PPAR 54 Avastin bevacizumab 54 geldanamycin 54 SCD1 54 PF # [002] 54 fumagillin 54 Xinlay 54 IgG1 monoclonal antibody 54 miR #a [002] 54 tumor suppressor 54 polymer conjugate technology 54 small molecule Hedgehog 54 LPA1 54 apoptosis proteins 54 microbubble 54 melatonin receptors 54 CCR9 antagonist 54 diabetic macular edema 54 HCV protease inhibitor 54 prostone 54 compound perifosine 54 small molecule PEGylation 54 protein CETP 54 immune stimulatory 54 HepDirect technology 54 Proxinium TM 54 nucleoside analogs 54 angiotensin receptor 54 γ secretase 54 Velcade bortezomib 54 SAR# [004] 54 Cytoxan 54 Cobalamin 54 TÎ ² 4 54 5 HT3 receptor 54 CEQ# 54 Aurora kinase inhibitors 54 SGLT2 inhibitors 54 theranostics 54 lipoic acid 54 cyclophilin inhibitors 54 monoclonal antibody 54 Cotara ® 54 Deforolimus 54 #beta HSD1 54 PI3K/Akt pathway inhibitor 54 NEUGENE 54 generation antisense 54 HCV protease 54 Eg5 54 Gamma secretase 54 Skp2 54 Avastin 54 Scorpion venom 54 VEGF protein 54 tenascin C 54 Sym# 54 nitric oxide donating 54 atacicept 54 PRX # 54 Rilutek 54 secretory diarrhea 54 biologic therapies 54 monoclonal antibody MAb 54 antiresorptive 54 Viprovex TM 54 insulin sensitizers 54 histone deacetylase inhibitor 54 ASC J9 54 CCR5 antagonists 54 synthetic peptide 54 immunotherapy 54 MUC1 * 54 HIF 1α 54 PLK1 SNALP 54 Adenosine Therapeutics 54 cardiotoxic 54 renin angiotensin aldosterone 54 Ad5FGF 4 54 Cetrorelix 54 Cladribine 54 EphA2 54 antimetabolite 54 Amevive 54 investigational monoclonal antibody 54 GW# [003] 54 darapladib 54 HCV replication 54 HER1 54 Lisofylline 54 olaparib 54 MAb 54 REOLYSIN ® 54 Valproic acid 54 antisense therapies 54 #ME# 54 taxane chemotherapy 54 beta secretase inhibitors 54 factor receptor FGFR 54 small molecule inhibitors 54 PTP 1B 54 FBPase 54 Receptos 54 Interferon alpha 54 Aurora Kinase 54 Golimumab 54 CYT# QbG# 54 monoclonal antibody therapies 54 mitotic kinesins 54 oral antiviral 54 HIF1 54 tiapamil 54 angiotensin receptor blockers 54 therapeutic antibody 54 pomalidomide 54 Rituximab 54 Nalmefene 54 HMG CoA reductase 54 Zarnestra 54 Histone deacetylase 54 integrase inhibitors 54 intranasal delivery 54 promising anticancer 54 Sudhir Agrawal D.Phil 54 Semafore 54 idiopathic pulmonary fibrosis IPF 54 HGS ETR1 54 serotonin reuptake 54 coagulation cascade 54 Orally administered 54 chemotherapeutics 54 NF kB pathway 54 Notch pathway 54 ADAMTS# 54 kallikrein 54 c myc gene 54 NFκB 54 Anti Phospholipid Therapy 54 Trophos 54 OMP #R# 54 proprietary polysaccharide 54 CD# antibodies 54 Tarceva erlotinib 54 Neulasta ® 54 cannabinoid receptor 54 PI3K/AKT 54 Bruton tyrosine kinase 54 Celator 54 sigma receptors 54 LEX System 54 Wnt pathway 54 MYDICAR ® 54 GV# [001] 54 angiotensin receptor blocker ARB 54 CB2 receptor 54 GRN# 54 CXCR7 54 Neuvenge 54 humanised monoclonal antibody 54 ErbB3 54 HER2 receptor 54 activin 54 cathepsins 54 G CSF 54 multiple myeloma MM 54 oral anticancer 54 peptide antigens 54 cyclin dependent kinase inhibitor 54 Erbitux cetuximab 54 plasma kallikrein 54 ERK pathway 54 Angiotensin II 54 bortezomib Velcade ® 54 oral anticoagulant 53 FTIs 53 Gleevec inhibits 53 DG# [001] 53 PI3K AKT 53 NFkappaB 53 PKC beta 53 endoplasmic reticulum stress 53 peptide hormone 53 Gleevec imatinib 53 solanezumab 53 TRO# 53 anti TNFs 53 humanized monoclonal 53 arterial thrombosis 53 ASA# 53 PKC alpha 53 TLR agonists 53 myelofibrosis polycythemia vera 53 mapatumumab 53 Preclinical studies suggest 53 CRAC channel 53 histone deacetylases 53 Angiolix R 53 mitogen activated ERK kinase 53 miR #b [002] 53 receptor modulators 53 humanized antibody 53 oral Janus kinase 53 CDK inhibitors 53 decitabine 53 tremelimumab 53 Viprinex 53 insulin sensitizer 53 CG# [003] 53 humanized anti 53 midstage trials 53 immunostimulatory 53 GVAX ® 53 tissue fibrosis 53 hematological indications 53 inhibit tumor angiogenesis 53 pazopanib 53 DNA gyrase 53 PROfusion 53 Vidaza R 53 DepoVax 53 SIRT1 53 antiproliferative 53 Tß4 53 fatty plaques 53 chemotherapeutic drugs 53 Voreloxin 53 Pemetrexed 53 telomerase therapeutic 53 aromatase 53 PEGylation 53 VEGFb 53 tubulin inhibitors 53 liposome encapsulated 53 PSMA ADC 53 Hsp# Inhibitor 53 RhuDex ® 53 Lpathomab 53 hedgehog signaling 53 Genentech Herceptin 53 Nicole Onetto MD 53 Calcitonin 53 apoptosis induced 53 inhibiting mTOR 53 EP #R 53 adenoviral 53 otelixizumab 53 orally administered inhibitor 53 antibody fragment therapeutics 53 NMDA receptor 53 protein homeostasis 53 cardiac glycosides 53 motesanib 53 delta opioid receptor 53 receptor antagonists 53 triggers apoptosis programmed 53 bispecific antibody 53 Galectin 53 oral JAK1 53 Flt3 53 IMGN# 53 TAp# 53 anti CD# antibodies 53 sargramostim 53 TNF Tumor Necrosis Factor 53 Ipilimumab 53 GGTase 53 Degarelix 53 SNT MC# 53 nicotinic acetylcholine receptor